Parameter
| Biomarker | MiR - 200 family | Full name | microRNA-200 family (e.g., miR-200a/b/c) | Molecular Type | Nucleic acid (miRNA) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis, prognosis and monitoring | ||
| Disease | Cholangiocarcinoma (CCA) | Disease Subtypes | / | ||
| Organ | Bile duct/Liver | Test Sample / Technology Platform | Serum/bile (qRT-PCR) | ||
| Pathobiological Mechanisms | Inhibition of EMT (targeting ZEB1/ZEB2) reduces tumor metastasis | ||||
| Clinical Availability Status | The validation; ECCA low expression suggests high shifting risk | ||||
| Notes and Dynamics | |||||